1. Home
  2. FSP vs BWAY Comparison

FSP vs BWAY Comparison

Compare FSP & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin Street Properties Corp.

FSP

Franklin Street Properties Corp.

HOLD

Current Price

$0.64

Market Cap

64.7M

Sector

Real Estate

ML Signal

HOLD

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

HOLD

Current Price

$12.82

Market Cap

450.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSP
BWAY
Founded
1981
2003
Country
United States
Israel
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
64.7M
450.8M
IPO Year
2001
N/A

Fundamental Metrics

Financial Performance
Metric
FSP
BWAY
Price
$0.64
$12.82
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$13.25
AVG Volume (30 Days)
611.6K
160.1K
Earning Date
03-09-2026
03-11-2026
Dividend Yield
6.49%
N/A
EPS Growth
15.69
N/A
EPS
N/A
N/A
Revenue
$107,162,000.00
N/A
Revenue This Year
$17.91
$301.23
Revenue Next Year
N/A
$24.33
P/E Ratio
N/A
$81.98
Revenue Growth
N/A
N/A
52 Week Low
$0.56
$7.84
52 Week High
$1.88
$26.63

Technical Indicators

Market Signals
Indicator
FSP
BWAY
Relative Strength Index (RSI) 45.29 29.70
Support Level $0.56 $11.55
Resistance Level $0.86 $13.63
Average True Range (ATR) 0.05 0.72
MACD 0.01 0.19
Stochastic Oscillator 53.03 17.62

Price Performance

Historical Comparison
FSP
BWAY

About FSP Franklin Street Properties Corp.

Franklin Street Properties Corp is a real estate investment trust. The company is focused on commercial real estate investments in office markets and currently operate in only one segment: real estate operations. The principal revenue sources for its real estate operations include rental income from real estate leasing, property dispositions and fee income from asset/property management and development. The company provides asset management, property management, property accounting, investor and/or development services to its portfolio and Sponsored REIT through the company's subsidiaries.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: